News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Joshua Richter: Newly updated NCCN guidelines
medicalnewstoday.com
Jan 4, 2025, 15:06

Joshua Richter: Newly updated NCCN guidelines

Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute, shared on X:

“Newly updated NCCN guidelines.

Now allows for prophylactic toci with Teclistamab.

Are you changing practice?”

Joshua Richter

cancer Joshua Richter NCCN NCCN guidelines OncoDaily Oncology teclistamab
Special Coverage
Insight
Jun 17, 2025, 15:30
Mario Occhipinti: Proud to Share Our Newly Published Cochrane Meta-Analysis
Opinion
Jun 17, 2025, 15:00
2025 Young Investigator Awardees Revealed by SIOP: Recognising Tomorrow’s Leaders
Blog
Jun 17, 2025, 14:45
Yan Leyfman: Great Gene Editing Keynote Highlighting the Promise and Potential of CAR-M Therapy
Blog
Jun 17, 2025, 14:35
Fumiko Ladd Chino: New ASCO Podcast - "Park the Parking"
Blog
Jun 17, 2025, 14:30
Sanofi Presented New Data in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma at EAACI 2025
Opinion
Jun 17, 2025, 14:28
Carmelo Gurnari: What a Nice EHA 2025
Blog
Jun 17, 2025, 14:18
Saleh Alessy: Pleased to See the Launch of The Lancet Oncology Series on Cancer Control
Insight
Jun 17, 2025, 13:50
Penn Medicine - Abramson Cancer Center Shared ASCO25 Study on ctDNA Blood Test For Breast Cancer
Blog
Jun 17, 2025, 12:04
Shehryar Nasir Khawaja: Looking Forward to Presenting Our Work On Postoperative Pain in Head and Neck Cancer Survivors at MASCC 2025
Blog
Jun 17, 2025, 11:38
Erman Akkus: Phase 1 Dual‐dose Escalation Study of Radiation and Nab‐paclitaxel in Pancreatic Cancer
Insight
Jun 17, 2025, 11:22
Dipesh Uprety Highlighted Phase 3 IMforte trial on First-line Maintenance Therapy With Lurbinectedin Plus Atezolizumab in SCLC
Blog
Jun 17, 2025, 11:08
New Funding Opportunity: Quality Improvement Grant Funding From Conquer Cancer's EveryGrant and Pfizer